Cardiac Natriuretic Peptides. Gaining Further Insights Into Structure-Function Relationships

Journal of the American College of Cardiology

Volumn 54, Issue 11, 2009, Pages 1033-1034

  de Bold, Adolfo J ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

angiotensin; blood pressure; heart failure; kidney; natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A;

ACUTE HEART INFARCTION; BLOOD VOLUME; CONGESTIVE HEART FAILURE; EDITORIAL; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; INFLAMMATION; PRIORITY JOURNAL; PROTEIN FUNCTION;

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; HEART DISEASES; HUMANS; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 69249169149     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.05.044     Document Type: Editorial

References (13)

1. de Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28 (1981) 89-94
2. Ramos H., and de Bold A.J. Gene expression, processing and secretion of natriuretic peptides: physiologic and diagnostic implications. Heart Fail Clin 2 (2006) 255-268
3. Rubattu S., Sciarretta S., Valenti V., Stanzione R., and Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 21 (2008) 733-741
4. Maisel A., Mueller C., Adams Jr. K., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10 (2008) 824-839
5. McGrath M.F., de Bold M.L., and de Bold A.J. The endocrine function of the heart. Trends Endocrinol Metab 16 (2005) 469-477
6. McKie P.M., Cataliotti A., Huntley B.K., Martin F.L., Olson T.M., and Burnett Jr. J.C. A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions. J Am Coll Cardiol 54 (2009) 1024-1032
7. Hodgson-Zingman D.M., Karst M.L., Zingman L.V., et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 359 (2008) 158-165
8. Baxter G.F. The natriuretic peptides. Basic Res Cardiol 99 (2004) 71-75
9. Tremblay J., Desjardins R., Hum D., Gutkowska J., and Hamet P. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem 230 (2002) 31-47
10. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 99 (2004) 76-82
11. Kasama S., Furuya M., Toyama T., Ichikawa S., and Kurabayashi M. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Eur Heart J 29 (2008) 1485-1494
12. Wang W., Ou Y., and Shi Y. AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure. Pharm Res 21 (2004) 2105-2111
13. Ogawa T., Forero McGrath M., et al. Role of potassium channels in stretch-promoted atrial natriuretic factor secretion. J Am Soc Hypertens 3 (2009) 9-18